B. Metzler seel. Sohn & Co. Holding AG Takes $5.08 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

B. Metzler seel. Sohn & Co. Holding AG bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 12,509 shares of the company's stock, valued at approximately $5,084,000.

A number of other hedge funds also recently made changes to their positions in the stock. Bangor Savings Bank grew its holdings in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company's stock worth $27,000 after acquiring an additional 45 shares during the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare during the second quarter worth about $28,000. GPS Wealth Strategies Group LLC boosted its holdings in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock valued at $31,000 after acquiring an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the firm's stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the firm's stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares of the company's stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 in the last 90 days. Insiders own 1.70% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Morgan Stanley assumed coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 price objective for the company. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research note on Monday, August 19th. KeyCorp reduced their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a report on Monday, October 28th. StockNews.com downgraded HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Monday, November 4th. Finally, Wells Fargo & Company raised their price objective on HCA Healthcare from $395.00 to $400.00 and gave the company an "equal weight" rating in a research note on Wednesday, November 6th. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $385.00.

HCA Healthcare Price Performance

Shares of NYSE:HCA traded down $2.11 during trading on Wednesday, reaching $333.00. The company had a trading volume of 1,426,476 shares, compared to its average volume of 1,189,091. The stock has a market capitalization of $84.35 billion, a P/E ratio of 14.95, a price-to-earnings-growth ratio of 1.32 and a beta of 1.68. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 12 month low of $245.84 and a 12 month high of $417.14. The company has a fifty day moving average of $381.99 and a two-hundred day moving average of $358.12.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.